Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Capecitabine and Cisplatin in Advanced Gastric Cancer
NCT01187212Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Asan Medical Center. Started Aug 2010; status: completed.
02
Drugs
sorafenib
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01187212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01187212.